The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Aclaris Therapeutics | COMM | 00461U105 | 11,450 | 1,911,573 | SH | SOLE | 1,911,573 | 0 | 0 | ||
Amarin | ADR | 023111206 | 108,124 | 5,208,305 | SH | SOLE | 5,208,305 | 0 | 0 | ||
Apellis Pharmaceuticals, Inc | COMM | 03753U106 | 967 | 49,580 | SH | SOLE | 49,580 | 0 | 0 | ||
Ascendis Pharma A/S | ADR | 04351P101 | 117,528 | 998,538 | SH | SOLE | 998,538 | 0 | 0 | ||
Audentes Therapeutics | COMM | 05070R104 | 36,431 | 933,640 | SH | SOLE | 933,640 | 0 | 0 | ||
Chiasma | COMM | 16706W102 | 8,477 | 1,630,221 | SH | SOLE | 1,630,221 | 0 | 0 | ||
Coherus BioSciences | COMM | 19249H103 | 39,123 | 2,868,221 | SH | SOLE | 2,868,221 | 0 | 0 | ||
Entasis Therapeutics Holdings Inc. | COMM | 293614103 | 7,972 | 1,180,178 | SH | SOLE | 1,180,178 | 0 | 0 | ||
Iterum Therapeutics | COMM | G6333L101 | 13,677 | 1,726,514 | SH | SOLE | 1,726,514 | 0 | 0 | ||
Kiniksa Pharmaceuticals, Ltd | COMM CL A | G5269C101 | 16,664 | 922,700 | SH | SOLE | 922,700 | 0 | 0 | ||
Merus N.V. | COMM | N5749R100 | 28,965 | 1,961,039 | SH | SOLE | 1,961,039 | 0 | 0 | ||
Natera | COMM | 632307104 | 63,934 | 3,100,560 | SH | SOLE | 3,100,560 | 0 | 0 | ||
Nucana Biomed Ltd | ADR | 67022C106 | 38,533 | 2,266,666 | SH | SOLE | 2,266,666 | 0 | 0 | ||
Nucana Biomed Ltd | Ordinary Shares | GB00BYWYV | 40,800 | 2,400,000 | SH | SOLE | 2,400,000 | 0 | 0 | ||
ObsEva SA | COMM | H5861P103 | 60,748 | 4,749,623 | SH | SOLE | 4,749,623 | 0 | 0 | ||
PDS Biotechnology Corporation | COMM | 70465T107 | 1,055 | 142,635 | SH | SOLE | 142,635 | 0 | 0 | ||
Principia Biopharma | COMM | 74257L108 | 69,299 | 2,038,208 | SH | SOLE | 2,038,208 | 0 | 0 | ||
Spark Therapeutics | COMM | 84652J103 | 54,807 | 481,270 | SH | SOLE | 481,270 | 0 | 0 | ||
Synlogic Inc. | COMM | 87166L100 | 4,364 | 574,972 | SH | SOLE | 574,972 | 0 | 0 | ||
Y-mAbs Therapeutics, Inc | COMM | 984241109 | 55,153 | 2,104,278 | SH | SOLE | 2,104,278 | 0 | 0 | ||
AbbVie Inc | COMM | 00287Y109 | 1,773 | 22,000 | SH | Call | SOLE | 22,000 | 0 | 0 | |
Adverum Biotechnologies Inc | COMM | 00773U108 | 123 | 23,394 | SH | SOLE | 23,394 | 0 | 0 | ||
Akebia Therapeutics Inc | COMM | 00972D105 | 631 | 77,067 | SH | SOLE | 77,067 | 0 | 0 | ||
Allergan plc | COMM | G0177J108 | 1,908 | 13,033 | SH | SOLE | 13,033 | 0 | 0 | ||
Alnylam Pharmaceuticals Inc | COMM | 02043Q107 | 1,464 | 15,664 | SH | SOLE | 15,664 | 0 | 0 | ||
Amicus Therapeutics Inc | COMM | 03152W109 | 1,187 | 87,285 | SH | SOLE | 87,285 | 0 | 0 | ||
AnaptysBio Inc | COMM | 032724106 | 1,032 | 14,132 | SH | SOLE | 14,132 | 0 | 0 | ||
ArQule Inc | COMM | 04269E107 | 253 | 52,779 | SH | SOLE | 52,779 | 0 | 0 | ||
AstraZeneca PLC | ADR | 046353108 | 1,580 | 39,088 | SH | SOLE | 39,088 | 0 | 0 | ||
Biogen Inc | COMM | 09062X103 | 1,418 | 6,000 | SH | Call | SOLE | 6,000 | 0 | 0 | |
Biohaven Pharmaceutical Holding Company Ltd | COMM | G11196105 | 945 | 18,358 | SH | SOLE | 18,358 | 0 | 0 | ||
Biomarin Pharmaceutical Inc | COMM | 09061G101 | 241 | 2,717 | SH | SOLE | 2,717 | 0 | 0 | ||
Blueprint Medicines Corp | COMM | 09627Y109 | 845 | 10,558 | SH | SOLE | 10,558 | 0 | 0 | ||
Clovis Oncology Inc | COMM | 189464100 | 243 | 9,795 | SH | SOLE | 9,795 | 0 | 0 | ||
Conatus Pharmaceuticals Inc | COMM | 20600T108 | 24 | 22,400 | SH | Call | SOLE | 22,400 | 0 | 0 | |
Deciphera Pharmaceuticals Inc | COMM | 24344T101 | 706 | 30,414 | SH | SOLE | 30,414 | 0 | 0 | ||
Dermira Inc | COMM | 24983L104 | 988 | 72,896 | SH | SOLE | 72,896 | 0 | 0 | ||
Fate Therapeutics Inc | COMM | 31189P102 | 544 | 30,936 | SH | SOLE | 30,936 | 0 | 0 | ||
FibroGen Inc | COMM | 31572Q958 | 408 | 7,500 | SH | Put | SOLE | 7,500 | 0 | 0 | |
FibroGen Inc | COMM | 31572Q808 | 465 | 8,554 | SH | SOLE | 8,554 | 0 | 0 | ||
Foamix Pharmaceuticals Ltd | COMM | M46135105 | 470 | 125,378 | SH | SOLE | 125,378 | 0 | 0 | ||
GW Pharmaceuticals PLC | ADR | 36197T103 | 495 | 2,938 | SH | SOLE | 2,938 | 0 | 0 | ||
Galapagos NV | COMM | 36315X101 | 353 | 3,000 | SH | Put | SOLE | 3,000 | 0 | 0 | |
Halozyme Therapeutics Inc | COMM | 40637H109 | 949 | 58,962 | SH | SOLE | 58,962 | 0 | 0 | ||
Heron Therapeutics Inc | COMM | 427746102 | 851 | 34,840 | SH | SOLE | 34,840 | 0 | 0 | ||
ImmunoGen Inc | COMM | 45253H101 | 61 | 22,600 | SH | Call | SOLE | 22,600 | 0 | 0 | |
Incyte Corp | COMM | 45337C102 | 685 | 7,960 | SH | SOLE | 7,960 | 0 | 0 | ||
Insmed Inc | COMM | 457669307 | 599 | 20,600 | SH | SOLE | 20,600 | 0 | 0 | ||
Intercept Pharmaceuticals Inc | COMM | 45845P108 | 738 | 6,600 | SH | SOLE | 6,600 | 0 | 0 | ||
Ishares Nasdaq Biotechnology | COMM | 464287956 | 2,370 | 21,200 | SH | Put | SOLE | 21,200 | 0 | 0 | |
Ishares Nasdaq Biotechnology | COMM | 464287956 | 1,643 | 14,700 | SH | Put | SOLE | 14,700 | 0 | 0 | |
Kadmon Holdings Inc | COMM | 48283N106 | 647 | 244,958 | SH | SOLE | 244,958 | 0 | 0 | ||
Kala Pharmaceuticals Inc | COMM | 483119103 | 426 | 51,489 | SH | SOLE | 51,489 | 0 | 0 | ||
MacroGenics Inc | COMM | 556099109 | 1,395 | 77,582 | SH | SOLE | 77,582 | 0 | 0 | ||
MorphoSys AG | COMM | D55040105 | 943 | 10,362 | SH | SOLE | 10,362 | 0 | 0 | ||
Neurocrine Biosciences Inc | COMM | 64125C109 | 1,456 | 16,523 | SH | SOLE | 16,523 | 0 | 0 | ||
Novo Nordisk A/S | ADR | 670100205 | 1,904 | 36,396 | SH | SOLE | 36,396 | 0 | 0 | ||
Orchard Therapeutics PLC | ADR | 68570P101 | 738 | 41,256 | SH | SOLE | 41,256 | 0 | 0 | ||
Osmotica Pharmaceuticals PLC | COMM | G6S41R101 | 133 | 36,901 | SH | SOLE | 36,901 | 0 | 0 | ||
Otonomy Inc | COMM | 68906L105 | 406 | 154,237 | SH | SOLE | 154,237 | 0 | 0 | ||
Portola Pharmaceuticals Inc | COMM | 737010108 | 153 | 4,408 | SH | SOLE | 4,408 | 0 | 0 | ||
Puma Biotechnology Inc | COMM | 74587V107 | 547 | 14,100 | SH | Call | SOLE | 14,100 | 0 | 0 | |
Reata Pharmaceuticals Inc | COMM | 75615P103 | 817 | 9,554 | SH | SOLE | 9,554 | 0 | 0 | ||
Savara Inc | COMM | 805111101 | 848 | 115,029 | SH | SOLE | 115,029 | 0 | 0 | ||
Syndax Pharmaceuticals Inc | COMM | 87164F105 | 165 | 31,363 | SH | SOLE | 31,363 | 0 | 0 | ||
TG Therapeutics Inc | COMM | 88322Q108 | 416 | 51,687 | SH | SOLE | 51,687 | 0 | 0 | ||
XBiotech Inc | COMM | 98400H102 | 423 | 38,413 | SH | SOLE | 38,413 | 0 | 0 | ||
Xencor Inc | COMM | 98401F105 | 974 | 31,366 | SH | SOLE | 31,366 | 0 | 0 | ||
AbbVie Inc | COMM | 00287Y109 | 3,417 | 42,400 | SH | Call | OTR | 1 | 42,400 | 0 | 0 |
Adverum Biotechnologies Inc | COMM | 00773U108 | 236 | 45,031 | SH | OTR | 1 | 45,031 | 0 | 0 | |
Akebia Therapeutics Inc | COMM | 00972D105 | 1,208 | 147,539 | SH | OTR | 1 | 147,539 | 0 | 0 | |
Allergan plc | COMM | G0177J108 | 3,671 | 25,076 | SH | OTR | 1 | 25,076 | 0 | 0 | |
Alnylam Pharmaceuticals Inc | COMM | 02043Q107 | 2,818 | 30,150 | SH | OTR | 1 | 30,150 | 0 | 0 | |
Amicus Therapeutics Inc | COMM | 03152W109 | 2,284 | 167,928 | SH | OTR | 1 | 167,928 | 0 | 0 | |
AnaptysBio Inc | COMM | 032724106 | 1,996 | 27,325 | SH | OTR | 1 | 27,325 | 0 | 0 | |
ArQule Inc | COMM | 04269E107 | 470 | 98,218 | SH | OTR | 1 | 98,218 | 0 | 0 | |
AstraZeneca PLC | ADR | 046353108 | 3,040 | 75,202 | SH | OTR | 1 | 75,202 | 0 | 0 | |
Biogen Inc | COMM | 09062X103 | 2,718 | 11,500 | SH | Call | OTR | 1 | 11,500 | 0 | 0 |
Biohaven Pharmaceutical Holding Company Ltd | COMM | G11196105 | 1,819 | 35,335 | SH | OTR | 1 | 35,335 | 0 | 0 | |
Biomarin Pharmaceutical Inc | COMM | 09061G101 | 465 | 5,230 | SH | OTR | 1 | 5,230 | 0 | 0 | |
Blueprint Medicines Corp | COMM | 09627Y109 | 1,627 | 20,323 | SH | OTR | 1 | 20,323 | 0 | 0 | |
Clovis Oncology Inc | COMM | 189464100 | 468 | 18,846 | SH | OTR | 1 | 18,846 | 0 | 0 | |
Conatus Pharmaceuticals Inc | COMM | 20600T108 | 47 | 43,100 | SH | Call | OTR | 1 | 43,100 | 0 | 0 |
Deciphera Pharmaceuticals Inc | COMM | 24344T101 | 1,370 | 59,040 | SH | OTR | 1 | 59,040 | 0 | 0 | |
Dermira Inc | COMM | 24983L104 | 1,816 | 134,033 | SH | OTR | 1 | 134,033 | 0 | 0 | |
Fate Therapeutics Inc | COMM | 31189P102 | 1,041 | 59,225 | SH | OTR | 1 | 59,225 | 0 | 0 | |
FibroGen Inc | COMM | 31572Q958 | 750 | 13,800 | SH | Put | OTR | 1 | 13,800 | 0 | 0 |
FibroGen Inc | COMM | 31572Q808 | 899 | 16,548 | SH | OTR | 1 | 16,548 | 0 | 0 | |
Foamix Pharmaceuticals Ltd | COMM | M46135105 | 865 | 230,742 | SH | OTR | 1 | 230,742 | 0 | 0 | |
GW Pharmaceuticals PLC | ADR | 36197T103 | 953 | 5,656 | SH | OTR | 1 | 5,656 | 0 | 0 | |
Galapagos NV | COMM | 36315X101 | 671 | 5,700 | SH | Put | OTR | 1 | 5,700 | 0 | 0 |
Halozyme Therapeutics Inc | COMM | 40637H109 | 1,827 | 113,492 | SH | OTR | 1 | 113,492 | 0 | 0 | |
Heron Therapeutics Inc | COMM | 427746102 | 1,630 | 66,699 | SH | OTR | 1 | 66,699 | 0 | 0 | |
ImmunoGen Inc | COMM | 45253H101 | 112 | 41,500 | SH | Call | OTR | 1 | 41,500 | 0 | 0 |
Incyte Corp | COMM | 45337C102 | 1,318 | 15,321 | SH | OTR | 1 | 15,321 | 0 | 0 | |
Insmed Inc | COMM | 457669307 | 1,153 | 39,650 | SH | OTR | 1 | 39,650 | 0 | 0 | |
Intercept Pharmaceuticals Inc | COMM | 45845P108 | 1,421 | 12,702 | SH | OTR | 1 | 12,702 | 0 | 0 | |
Ishares Nasdaq Biotechnology | COMM | 464287956 | 4,561 | 40,800 | SH | Put | OTR | 1 | 40,800 | 0 | 0 |
Ishares Nasdaq Biotechnology | COMM | 464287956 | 3,164 | 28,300 | SH | Put | OTR | 1 | 28,300 | 0 | 0 |
Kadmon Holdings Inc | COMM | 48283N106 | 1,238 | 468,954 | SH | OTR | 1 | 468,954 | 0 | 0 | |
Kala Pharmaceuticals Inc | COMM | 483119103 | 815 | 98,572 | SH | OTR | 1 | 98,572 | 0 | 0 | |
MacroGenics Inc | COMM | 556099109 | 2,685 | 149,309 | SH | OTR | 1 | 149,309 | 0 | 0 | |
MorphoSys AG | COMM | D55040105 | 1,815 | 19,936 | SH | OTR | 1 | 19,936 | 0 | 0 | |
Neurocrine Biosciences Inc | COMM | 64125C109 | 2,801 | 31,791 | SH | OTR | 1 | 31,791 | 0 | 0 | |
Novo Nordisk A/S | ADR | 670100205 | 3,665 | 70,057 | SH | OTR | 1 | 70,057 | 0 | 0 | |
Orchard Therapeutics PLC | ADR | 68570P101 | 1,419 | 79,372 | SH | OTR | 1 | 79,372 | 0 | 0 | |
Osmotica Pharmaceuticals PLC | COMM | G6S41R101 | 270 | 74,997 | SH | OTR | 1 | 74,997 | 0 | 0 | |
Otonomy Inc | COMM | 68906L105 | 747 | 283,853 | SH | OTR | 1 | 283,853 | 0 | 0 | |
Portola Pharmaceuticals Inc | COMM | 737010108 | 294 | 8,484 | SH | OTR | 1 | 8,484 | 0 | 0 | |
Puma Biotechnology Inc | COMM | 74587V107 | 1,043 | 26,900 | SH | Call | OTR | 1 | 26,900 | 0 | 0 |
Reata Pharmaceuticals Inc | COMM | 75615P103 | 1,572 | 18,390 | SH | OTR | 1 | 18,390 | 0 | 0 | |
Savara Inc | COMM | 805111101 | 1,624 | 220,335 | SH | OTR | 1 | 220,335 | 0 | 0 | |
Syndax Pharmaceuticals Inc | COMM | 87164F105 | 317 | 60,343 | SH | OTR | 1 | 60,343 | 0 | 0 | |
TG Therapeutics Inc | COMM | 88322Q108 | 800 | 99,489 | SH | OTR | 1 | 99,489 | 0 | 0 | |
XBiotech Inc | COMM | 98400H102 | 815 | 73,922 | SH | OTR | 1 | 73,922 | 0 | 0 | |
Xencor Inc | COMM | 98401F105 | 1,874 | 60,346 | SH | OTR | 1 | 60,346 | 0 | 0 | |
AbbVie Inc | COMM | 00287Y109 | 6,899 | 85,600 | SH | Call | OTR | 2 | 85,600 | 0 | 0 |
Adverum Biotechnologies Inc | COMM | 00773U108 | 476 | 90,812 | SH | OTR | 2 | 90,812 | 0 | 0 | |
Akebia Therapeutics Inc | COMM | 00972D105 | 2,393 | 292,155 | SH | OTR | 2 | 292,155 | 0 | 0 | |
Allergan plc | COMM | G0177J108 | 7,402 | 50,556 | SH | OTR | 2 | 50,556 | 0 | 0 | |
Alnylam Pharmaceuticals Inc | COMM | 02043Q107 | 5,682 | 60,802 | SH | OTR | 2 | 60,802 | 0 | 0 | |
Amicus Therapeutics Inc | COMM | 03152W109 | 4,473 | 328,895 | SH | OTR | 2 | 328,895 | 0 | 0 | |
AnaptysBio Inc | COMM | 032724106 | 4,127 | 56,491 | SH | OTR | 2 | 56,491 | 0 | 0 | |
ArQule Inc | COMM | 04269E107 | 981 | 204,728 | SH | OTR | 2 | 204,728 | 0 | 0 | |
AstraZeneca PLC | ADR | 046353108 | 5,955 | 147,287 | SH | OTR | 2 | 147,287 | 0 | 0 | |
Biogen Inc | COMM | 09062X103 | 5,319 | 22,500 | SH | Call | OTR | 2 | 22,500 | 0 | 0 |
Biohaven Pharmaceutical Holding Company Ltd | COMM | G11196105 | 3,668 | 71,259 | SH | OTR | 2 | 71,259 | 0 | 0 | |
Biomarin Pharmaceutical Inc | COMM | 09061G101 | 937 | 10,547 | SH | OTR | 2 | 10,547 | 0 | 0 | |
Blueprint Medicines Corp | COMM | 09627Y109 | 3,281 | 40,985 | SH | OTR | 2 | 40,985 | 0 | 0 | |
Clovis Oncology Inc | COMM | 189464100 | 943 | 37,994 | SH | OTR | 2 | 37,994 | 0 | 0 | |
Conatus Pharmaceuticals Inc | COMM | 20600T108 | 91 | 84,500 | SH | Call | OTR | 2 | 84,500 | 0 | 0 |
Deciphera Pharmaceuticals Inc | COMM | 24344T101 | 2,905 | 125,150 | SH | OTR | 2 | 125,150 | 0 | 0 | |
Dermira Inc | COMM | 24983L104 | 3,749 | 276,711 | SH | OTR | 2 | 276,711 | 0 | 0 | |
Fate Therapeutics Inc | COMM | 31189P102 | 1,996 | 113,581 | SH | OTR | 2 | 113,581 | 0 | 0 | |
FibroGen Inc | COMM | 31572Q958 | 1,560 | 28,700 | SH | Put | OTR | 2 | 28,700 | 0 | 0 |
FibroGen Inc | COMM | 31572Q808 | 1,843 | 33,915 | SH | OTR | 2 | 33,915 | 0 | 0 | |
Foamix Pharmaceuticals Ltd | COMM | M46135105 | 1,786 | 476,173 | SH | OTR | 2 | 476,173 | 0 | 0 | |
GW Pharmaceuticals PLC | ADR | 36197T103 | 1,923 | 11,406 | SH | OTR | 2 | 11,406 | 0 | 0 | |
Galapagos NV | COMM | 36315X101 | 1,331 | 11,300 | SH | Put | OTR | 2 | 11,300 | 0 | 0 |
Halozyme Therapeutics Inc | COMM | 40637H109 | 3,685 | 228,875 | SH | OTR | 2 | 228,875 | 0 | 0 | |
Heron Therapeutics Inc | COMM | 427746102 | 3,229 | 132,112 | SH | OTR | 2 | 132,112 | 0 | 0 | |
ImmunoGen Inc | COMM | 45253H101 | 233 | 85,900 | SH | Call | OTR | 2 | 85,900 | 0 | 0 |
Incyte Corp | COMM | 45337C102 | 2,564 | 29,816 | SH | OTR | 2 | 29,816 | 0 | 0 | |
Insmed Inc | COMM | 457669307 | 2,320 | 79,807 | SH | OTR | 2 | 79,807 | 0 | 0 | |
Intercept Pharmaceuticals Inc | COMM | 45845P108 | 2,865 | 25,616 | SH | OTR | 2 | 25,616 | 0 | 0 | |
Ishares Nasdaq Biotechnology | COMM | 464287956 | 6,373 | 57,000 | SH | Put | OTR | 2 | 57,000 | 0 | 0 |
Ishares Nasdaq Biotechnology | COMM | 464287956 | 8,944 | 80,000 | SH | Put | OTR | 2 | 80,000 | 0 | 0 |
Kadmon Holdings Inc | COMM | 48283N106 | 2,529 | 957,858 | SH | OTR | 2 | 957,858 | 0 | 0 | |
Kala Pharmaceuticals Inc | COMM | 483119103 | 1,615 | 195,285 | SH | OTR | 2 | 195,285 | 0 | 0 | |
MacroGenics Inc | COMM | 556099109 | 5,338 | 296,865 | SH | OTR | 2 | 296,865 | 0 | 0 | |
MorphoSys AG | COMM | D55040105 | 3,555 | 39,046 | SH | OTR | 2 | 39,046 | 0 | 0 | |
Neurocrine Biosciences Inc | COMM | 64125C109 | 5,647 | 64,092 | SH | OTR | 2 | 64,092 | 0 | 0 | |
Novo Nordisk A/S | ADR | 670100205 | 7,390 | 141,281 | SH | OTR | 2 | 141,281 | 0 | 0 | |
Orchard Therapeutics PLC | ADR | 68570P101 | 2,780 | 155,455 | SH | OTR | 2 | 155,455 | 0 | 0 | |
Osmotica Pharmaceuticals PLC | COMM | G6S41R101 | 508 | 141,191 | SH | OTR | 2 | 141,191 | 0 | 0 | |
Otonomy Inc | COMM | 68906L105 | 1,541 | 585,775 | SH | OTR | 2 | 585,775 | 0 | 0 | |
Portola Pharmaceuticals Inc | COMM | 737010108 | 594 | 17,108 | SH | OTR | 2 | 17,108 | 0 | 0 | |
Puma Biotechnology Inc | COMM | 74587V107 | 2,048 | 52,800 | SH | Call | OTR | 2 | 52,800 | 0 | 0 |
Reata Pharmaceuticals Inc | COMM | 75615P103 | 3,170 | 37,087 | SH | OTR | 2 | 37,087 | 0 | 0 | |
Savara Inc | COMM | 805111101 | 3,179 | 431,308 | SH | OTR | 2 | 431,308 | 0 | 0 | |
Syndax Pharmaceuticals Inc | COMM | 87164F105 | 639 | 121,653 | SH | OTR | 2 | 121,653 | 0 | 0 | |
TG Therapeutics Inc | COMM | 88322Q108 | 1,613 | 200,635 | SH | OTR | 2 | 200,635 | 0 | 0 | |
XBiotech Inc | COMM | 98400H102 | 1,643 | 149,056 | SH | OTR | 2 | 149,056 | 0 | 0 | |
Xencor Inc | COMM | 98401F105 | 3,671 | 118,195 | SH | OTR | 2 | 118,195 | 0 | 0 |